UroGen Pharma Ltd. (URGN)
NASDAQ·Healthcare·Biotechnology
$33.75
-0.47%
Mkt Cap $1.69B
Analyst Ratings
Buy
10
Hold
0
Sell
0
Price Target (18 analysts)
$56.60
Range $44.00 – $75.00
Implied Upside
+67.7%
Consensus $56.60 vs current $33.75
NASDAQ·Healthcare·Biotechnology
$33.75
-0.47%
Mkt Cap $1.69B
Buy
10
Hold
0
Sell
0
Price Target (18 analysts)
$56.60
Range $44.00 – $75.00
+67.7%
Consensus $56.60 vs current $33.75